--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q292.000K / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
NGNE Neurogene
- 22.640
- +0.565+2.56%
Close Dec 20 16:00 ET
- 22.640
- 0.0000.00%
Post 16:00 ET
336.31MMarket Cap-7.99P/E (TTM)
23.890High21.510Low466.32KVolume21.780Open22.075Pre Close10.66MTurnover8.68%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High2.45P/B121.64MFloat Cap14.44052wk Low--Dividend TTM5.37MShs Float1115.000Historical High--Div YieldTTM10.78%Amplitude7.500Historical Low22.869Avg Price1Lot Size
Neurogene Key Stats
Neurogene Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Neurogene Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data